141 related articles for article (PubMed ID: 27074937)
21. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
24. Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Alessi S; Maggioni R; Luzzago S; Colombo A; Pricolo P; Summers PE; Saia G; Manzoni M; Renne G; Marvaso G; De Cobelli O; Bellomi M; Jereczek-Fossa BA; Petralia G
Clin Genitourin Cancer; 2021 Dec; 19(6):e335-e345. PubMed ID: 34023239
[TBL] [Abstract][Full Text] [Related]
25. Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 99(2):215-221. PubMed ID: 28245478
[TBL] [Abstract][Full Text] [Related]
26. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
28. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
29. Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center.
Di Mauro E; Di Bello F; Califano G; Morra S; Creta M; Celentano G; Abate M; Fraia A; Pezone G; Marino C; Cilio S; Capece M; La Rocca R; Imbimbo C; Longo N; Colla' Ruvolo C
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984626
[No Abstract] [Full Text] [Related]
30. Intravoxel incoherent motion predicts positive surgical margins and Gleason score upgrading after radical prostatectomy for prostate cancer.
Meng S; Gan W; Chen L; Wang N; Liu A
Radiol Med; 2023 Jun; 128(6):668-678. PubMed ID: 37277573
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression Score.
Renard-Penna R; Cancel-Tassin G; Comperat E; Varinot J; Léon P; Roupret M; Mozer P; Vaessen C; Lucidarme O; Bitker MO; Cussenot O
J Urol; 2015 Dec; 194(6):1617-23. PubMed ID: 26272031
[TBL] [Abstract][Full Text] [Related]
34. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
[TBL] [Abstract][Full Text] [Related]
35. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
[TBL] [Abstract][Full Text] [Related]
36. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
[TBL] [Abstract][Full Text] [Related]
37. Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System.
Porcaro AB; Siracusano S; De Luyk N; Corsi P; Sebben M; Tafuri A; Bizzotto L; Tamanini I; Inverardi D; Cerruto MA; Martignoni G; Brunelli M; Artibani W
Urol Int; 2016; 97(1):32-41. PubMed ID: 26998904
[TBL] [Abstract][Full Text] [Related]
38. Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer.
Hara T; Nakanishi H; Nakagawa T; Komiyama M; Kawahara T; Manabe T; Miyake M; Arai E; Kanai Y; Fujimoto H
Int J Urol; 2013 Oct; 20(10):993-9. PubMed ID: 23360237
[TBL] [Abstract][Full Text] [Related]
39. Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study.
Hwang I; Lim D; Jeong YB; Park SC; Noh JH; Kwon DD; Kang TW
Asian J Androl; 2015; 17(5):811-4. PubMed ID: 25578934
[TBL] [Abstract][Full Text] [Related]
40. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.
Freedland SJ; Kane CJ; Amling CL; Aronson WJ; Terris MK; Presti JC;
Urology; 2007 Mar; 69(3):495-9. PubMed ID: 17382152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]